Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here

Pricing and Ordering Information

 

U.S. Markets for Interventional Cardiology Products
Report #A209
- May 2014
270 Pages – 68 Exhibits


Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from coronary heart disease (CHD), which is the single largest cause of death in the U.S. and also is the greatest cause of premature and permanent disability in the labor force; CHD is responsible for more than 50% of all cardiovascular events in men and women younger than age 75, and for 1 out of every 6 deaths.

Interventional cardiology is a continually evolving area of medicine that involves the use of catheter-based, or transcatheter, tools and techniques to diagnose and treat coronary vascular and structural disorders. Today, interventional techniques, which came into widespread use in the mid-1980s, are a mainstay for the diagnosis and treatment of patients with CHD. In 2013, diagnostic and therapeutic interventional cardiology methods were employed in approximately 5.5 million procedures in the U.S., generating approximately $3.8 billion in corresponding products sales; it is expected that, in the year 2018, these methods will be employed in nearly 5.7 million procedures in the U.S., generating an estimated $4.3 billion in corresponding product sales.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional cardiology devices to the U.S.

Covered topics in this report include atherectomy, cardiovascular disease statistics, coronary angiography, coronary stenting, drug-eluting balloon angioplasty, guidewire-based physiologic intravascular stenosis assessment, intracardiac echocardiography, intravascular ultrasound, percutaneous transluminal coronary angioplasty, thrombectomy, transcatheter septal defect repair, and vascular access site closure, among others.

Ordering Information

Title

Report# Publication
Date
List Price

U.S. Markets for Interventional Cardiology Products

A209

May 2014

$4,750

Order Online:
Single User only (Please call for corporate subscription pricing)
PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

EXECUTIVE SUMMARY

i.          Diagnostic Interventional Cardiology Products

a.         Coronary Angiography Systems

b.         Guidewire-Based Physiologic Intravascular
Stenosis Assessment Products

c.          Intracardiac Echocardiography Products

d.         Intravascular Ultrasound Products

ii.          Therapeutic Interventional Cardiology Products

a.         Percutaneous Transluminal Coronary
Angiography Devices

b.         Coronary Stent Systems

c.          Atherectomy Systems

d.         Thrombectomy Systems

e.         Transcatheter Septal Defect Repair Devices

f.          Vascular Access Site Closure Devices

iii.         Methodology

Exhibit ES-1:       Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018

Exhibit ES-2:       Interventional Cardiology Products, Combined Market Forecast, 2013-2018

Exhibit ES-3:       Diagnostic Interventional Cardiology Systems Market Share, by Product Segment,
2013 and 2018

Exhibit ES-4:       Therapeutic Interventional Systems Market Share, by Product Segment, 2013 and 2018

 

1.         Heart Disease Overview

1.1        The Heart and Circulatory System

1.2        Selected Heart Diseases/Disorders

1.2.1     Coronary Heart Disease

1.2.1.1  Atherosclerosis

1.2.1.2  Angina Pectoris

1.2.1.3  Myocardial Infarction

1.2.2     Hypertension

1.2.2.1  Systolic and Diastolic Pressures

1.2.2.2  Prehypertension

1.2.3     Cardiomyopathy

1.2.3.1  Dilated Cardiomyopathy

1.2.3.2  Hypertrophic Cardiomyopathy

1.2.3.3  Restrictive Cardiomyopathy

1.2.4     Congenital Heart Defects

1.2.4.1  Ventricular Septal Defects

1.2.4.2  Atrial Septal Defects

1.2.4.3  Patent Ductus Arteriosus

1.2.5     Heart Failure

1.2.5.1  Disease Development

1.2.5.2  Ejection Fraction Reduction

1.2.5.3  Classification/Staging Systems

Exhibit 1-1:        Cross-Section Diagram of the Heart

Exhibit 1-2:        Statistics for Selected Coronary Heart Disease Risk Factors

Exhibit 1-3:        Standard Angina Pectoris Classification

Exhibit 1-4:        Angina Pectoris, Selected Statistics

Exhibit 1-5:        Clinical Classification of AMI

Exhibit 1-6:        Myocardial Infarction, Selected Statistics

Exhibit 1-7:        Percentage of Adults Who Have Been Told They Have High Blood Pressure, by State

Exhibit 1-8:        Hypertension, Selected Statistics

Exhibit 1-9:        Cardiomyopathy, Selected Statistics

Exhibit 1-10:      Congenital Heart Defects, Selected Statistics

Exhibit 1-11:      Summary, New York Heart Association Heart Failure Classification System

Exhibit 1-12:      Summary, ACCF/AHA Failure Staging System

Exhibit 1-13:      Heart Failure, Selected Statistics

 

2.         Diagnostic Interventional Cardiology Procedures and Products

2.1        Coronary Angiography

2.1.1     Technologies

2.1.2     Procedure Volumes

2.1.3     Products

2.1.4     Market Forecast

2.1.5     Competitors

2.2        Guidewire-Based Physiologic Intravascular
Stenosis Assessment

2.2.1     Technologies

2.2.2     Procedure Volumes

2.2.3     Products

2.2.4     Market Forecast

2.2.5     Competitors

2.3        Intracardiac Echocardiography

2.3.1     Technologies

2.3.2     Procedure Volumes

2.3.3     Products

2.3.4     Market Forecast

2.3.5     Competitors

2.4        Intravascular Ultrasound

2.4.1     Technologies

2.4.2     Procedure Volumes

2.4.3     Products

2.4.4     Market Forecast

2.4.5     Competitors

Exhibit 2-1:        Diagnostic Interventional Cardiology, Combined Procedure Volumes Forecast, 2013-2018

Exhibit 2-2:        Diagnostic Interventional Cardiology Products, Combined Market Forecast, 2013-2018

Exhibit 2-3:        Coronary Angiography,
Procedure Volumes Forecast, 2013-2018

Exhibit 2-4:        2014, Selected Angiography Catheters

Exhibit 2-5:        2014, Selected Diagnostic Guidewires

Exhibit 2-6:        2014, Selected Introducers/Sheaths

Exhibit 2-7:        Coronary Angiography Devices, Market Forecast, 2013-2018

Exhibit 2-8:        2013, Coronary Angiography Devices Market, Share by Supplier

Exhibit 2-9:        Guidewire-Based Physiologic Intravascular Stenosis Assessment, Procedure Volumes, 2013-2018

Exhibit 2-10:      2014, Selected Consoles and Guidewires for Physiologic Intravascular Stenosis Assessment

Exhibit 2-11:      Physiologic Intravascular Stenosis Assessment Guidewires, Market Forecast, 2013-2018

Exhibit 2-12:      2013, Physiologic Intravascular Stenosis Assessment Guidewire Systems Market,
Share by Supplier

Exhibit 2-13:      Intracardiac Echocardiography,
Procedure Volumes Forecast,
2013-2018

Exhibit 2-14:      2014, Selected Intracardiac
Echocardiography Catheters

Exhibit 2-15:      Intracardiac Echocardiography Catheters, Market Forecast, 2013-2018

Exhibit 2-16:      2013, Intracardiac Echocardiography Catheters Market, Share by Supplier

Exhibit 2-17:      Intravascular Ultrasound,
Procedure Volumes Forecast, 2013-2018

Exhibit 2-18:      2014, Selected Intravascular
Ultrasound Products

Exhibit 2-19:      Intravascular Ultrasound Products,
Market Forecast, 2013-2018

Exhibit 2-20:      2013, Intravascular Ultrasound Products Market, Share by Supplier

 

3.         Therapeutic interventional cardiology procedures and products

3.1        Percutaneous Transluminal Coronary Angioplasty

3.1.1     Technologies

3.1.1.1  Approaches

3.1.1.2  Complications/Efficacy

3.1.2     Procedure Volumes Forecast

3.1.3     Products

3.1.3.1  Balloon Catheters

3.1.3.2  Guiding Catheters

3.1.3.3  Guidewires

3.1.3.4  Introducers/Sheaths

3.1.3.5  Accessories

3.1.4     Market Forecast

3.1.5     Competitors

3.2        Coronary Stenting

3.2.1     Technologies

3.2.2     Procedure Volumes Forecast

3.2.3     Products

3.2.4     Market Forecast

3.2.5     Competitors

3.3        Coronary Atherectomy

3.3.1     Technologies

3.3.2     Procedure Volumes Forecast

3.3.3     Products

3.3.4     Market Forecast

3.3.5     Competitors

3.4        Coronary Thrombectomy

3.4.1     Technologies

3.4.2     Procedures Volumes Forecast

3.4.3     Products

3.4.4     Market Forecast

3.4.5     Competitors

3.5        Transcatheter Septal Defect Repair

3.5.1     Technologies

3.5.2     Procedure Volumes Forecast

3.5.3     Products

3.5.4     Market Forecast

3.5.5     Competitors

3.6        Vascular Access Site Closure Devices

3.6.1     Technologies

3.6.2     Procedure Volumes Forecast

3.6.3     Products

3.6.4     Market Forecast

3.6.5     Competitors

Exhibit 3-1:        Therapeutic Interventional Cardiology, Combined Procedure Volumes Forecast,
2013-2018

Exhibit 3-2:        Therapeutic Interventional Cardiology Products, Combined Market Forecast, 2013-2018

Exhibit 3-3:        Percutaneous Transluminal Coronary Angioplasty, Procedure Volumes Forecast, 2013-2018

Exhibit 3-4:        2014, Selected Percutaneous Transluminal Coronary Angioplasty Balloon Catheters

Exhibit 3-5:        2014, Selected Guiding Catheters for Coronary Interventions

Exhibit 3-6:        2014, Selected Guidewires for Coronary Interventions

Exhibit 3-7:        2014, Selected Introducers/Sheaths for Coronary Interventions

Exhibit 3-8:        2014, Selected Inflation Devices for Coronary Interventions

Exhibit 3-9:        Percutaneous Transluminal Coronary Angioplasty Devices, Market Forecast,
2013-2018

Exhibit 3-10:      2013, Percutaneous Transluminal Coronary Angioplasty Devices Market, Share by Supplier

Exhibit 3-11:      2014, Selected Anti-Restenosis Agents

Exhibit 3-12:      Coronary Stenting, Procedure Volumes Forecast, 2013-2018

Exhibit 3-13:      2014, Selected Coronary Stent Systems/Stents

Exhibit 3-14:      Coronary Stent Systems,
Market Forecast, 2013-2018

Exhibit 3-15:      2013, Coronary Stent Systems Market,
Share by Supplier

Exhibit 3-16:      Coronary Atherectomy, Procedure Volumes Forecast, 2013-2018

Exhibit 3-17:      2014, Selected Coronary Atherectomy Systems

Exhibit 3-18:      Coronary Atherectomy Systems, Market Forecast, 2013-2018

Exhibit 3-19:      2013, Coronary Atherectomy Systems Market, Share by Supplier

Exhibit 3-20:      Coronary Thrombectomy, Procedure Volumes Forecast, 2013-2018

Exhibit 3-21:      2014, Selected Thrombectomy Systems

Exhibit 3-22:      Coronary Thrombectomy Systems, Market Forecast, 2013-2018

Exhibit 3-23:      2013, Coronary Thrombectomy Systems Market, Share by Supplier

Exhibit 3-24:      Transcatheter Septal Defect Repair, Procedure Volumes Forecast, 2013-2018

Exhibit 3-25:      2014, Selected Transcatheter Septal Defect Repair Devices

Exhibit 3-26:      Transcatheter Septal Defect Repair Devices, Market Forecast, 2013-2018

Exhibit 3-27:      2013, Transcatheter Septal Defect Repair Devices Market, Share by Supplier

Exhibit 3-28:      Vascular Access Site Closure, Procedure Volumes Forecast, 2008-2013

Exhibit 3-29:      2014, Selected Vascular Site Closure Devices

Exhibit 3-30:      Vascular Access Site Closure Devices, Market Forecast, 2013-2018

Exhibit 3-31:      2013, Vascular Access Site Closure Devices Market, Share by Supplier

 

appendix:  company listing

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact custcare@informa.com. You can also call 1.908.748.1221 (or toll-free within the U.S. at 1.800.332.2181) or fax 1.908.748.1222.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home